Bernstein Upgrades Beam Therapeutics(BEAM.US) to Buy Rating, Raises Target Price to $37

Futu NewsJan 8 01:31 · Ratings

Beam Upgraded by Bernstein Ahead of AATD Data

Seeking AlphaJan 8 01:01

Express News | Beam Therapeutics Inc : Bernstein Raises to Outperform From Market Perform; Raises Target Price to $37 From $35

BreakingsJan 7 16:54

Beam Therapeutics Inc. (BEAM): Is This Gene Therapy Stock a Good Buy Right Now?

Yahoo FinanceDec 29, 2024 19:28

New Strategy? Cathie Wood's ARK Purchases Shares in Futu, Significantly Increased Its Stake in AI Healthcare Company Tempus AI and Sold Off Shopify

Cathie Wood's ARK ETF announced the daily Trade details for Tuesday, December 17, 2024.

Futu NewsDec 18, 2024 18:22

Beam Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireDec 17, 2024 20:00